United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Vergent Bioscience’s breakthrough at STS 2024: VGT-309 enhances lung cancer surgery At the 60th Annual Meeting of The Society of Thoracic Surgeons (#STS2024), Vergent Bioscience, a Minneapolis-based clinical-stage biotechnology… byPallavi MadhirajuJanuary 29, 2024